Ball L, Ball R, Pratt RD. An assessment of thimerosal in childhood vaccines. Pediatrics 2001;107:1147–1154.
Förström L, Hannulksela M, Kousa M, Lehmuskallio E. Merthiolate hypersensitivity and vaccination. Contact Dermatitis 1980;6:241–245.
Jacobs RL, Lowe RS, Lanier BQ. Adverse reactions to tetanus toxoid. Journal of the American Medical Association 1982;247(1):40–42.
The American Academy of Family Physicians, American Academy of Pediatrics, Advisory Committee on Immunization Practices, and United States Public Health Service. Joint statement concerning removal of thimerosal from vaccines. Approved June 22, 2000.
Mahaffey KR. Methylmercury: A new look at the risks. Public Health Reports 1999;114(5):396–399, 402–413.
Pichichero ME, Cernichiari E, Lopreiato J, Treanor J. Mercury concentrations and metabolism in infants receiving vaccines containing thimerosal: a descriptive study. Lancet 2002;360(9347):1737–1741.
Agency for Toxic Substances and Disease Registry, Public Health Service, U.S. Department of Health and Human Services. Toxicological Profile for Mercury (Update). Atlanta, GA, 1999.